SCYNEXIS (SCYX) Earnings Date & Reports

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

SCYX is expected to report earnings to fall 197.35% to -61 cents per share on November 11

Q3'26

Est.

$-0.61

Q2'26

Beat

by $1.14

Q1'26

Missed

by $2.32

Q4'25

Beat

by $0.12

Q3'25

Beat

by $0.03

The last earnings report on August 10 showed earnings per share of 62 cents, beating the estimate of -50 cents. With 279.37K shares outstanding, the current market capitalization sits at 45.97M.

View a ticker or compare two or three

SCYX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for SCYX